The active molecules in cannabis kill brain cancer — another study has revealed.
Scientists using an extract of whole-plant marijuana rich in pot’s main psychoactive ingredient THC as well as cannabidiol (CBD) showed “dramatic reductions in tumor volumes” of a type of brain cancer.
Writing in Molecular Cancer Therapeutics this month, the team recounts how they decided to build on existing research that shows “cannabinoids have been shown to specifically inhibit glioma growth as well as neutralize oncogenic processes such as angiogenesis.”
The researchers wanted to boost the success of cannabinoids, so they investigated using THC and CBD both alone and in combination with radiation in a number of glioma cell lines.
Marijuana kills cancer cells in proportion to its dose and duration of treatment, researchers found, and whole plant cannabis rich in THC was more efficacious than pure, lab-grade THC alone.
What they found was complex, but the pattern was clear: The brains of marijuana users were different than those of non-marijuana users. The area of the brain responsible for establishing the reward system that helps us survive and also keeps us motivated was smaller in users than in non-marijuana users. But there was also evidence that the brain compensated for this loss of volume by increasing connectivity and the structural integrity of the brain tissue.
Those effects were more pronounced for marijuana users who started young.
The poll of roughly 35,000 American households provides the first snapshot of the pain landscape in the United States, the survey authors said.
The bottom line: Significant and debilitating pain that endures for three months or more is now a common feature in the lives of an estimated 39 million Americans.
U.S. District Judge Kimberly Mueller, who granted the hearing, scheduled for three days, over prosecutors’ objections. In an April 22 order, she said lawyers for the defendants had presented expert declarations “showing there is new scientific and medical information raising contested issues of fact regarding whether the continued inclusion of marijuana as a Schedule One controlled substance ... passes constitutional muster.”
She issued the order in a case that, based on the evidence so far, has little to do with medical marijuana — the defendants are charged with growing a large tract of pot plants on forest land, and there’s been no indication that it was for medical use. But Gilg said that’s irrelevant if they were charged under an unconstitutional law.
As Gilg acknowledges, it will not be an easy case to win. She and her colleagues must prove not merely that the federal law is misguided, based on current research, but that it is entirely irrational. An initial ruling would apply only to the current defendants, but the impact would be broader if higher courts weighed in.
Monday in California when a federal judge is scheduled to hear testimony from doctors that conclude the opposite.
Doctors Carl Hart, Associate Professor of Psychology at Columbia University, retired physician Phillip Denny, and Greg Carter, Medical Director of St. Luke’s Rehabilitation Institute in Spokane, Washington will testify Monday that marijuana — real name, “cannabis” — is not the demon drug the federal government makes it out to be. Accepted science does not justify the listing of cannabis as a dangerous “Schedule I” substance, many say.
Attorneys Zenia Gilg and Heather Burke write that “In effect, the action taken by the Department of Justice is either irrational, or more likely proves … [that] marijuana does not fit the criteria of a Schedule I Controlled Substance.”
Testimony for the evidentiary hearing of United States v. Pickard, et. al., should last three days.
NEW YORK (Reuters Health) - A long-term study of Swedish men finds that those who smoked marijuana at age 18, especially the heaviest users, were more likely to end up on the nation’s disability rolls by age 59.
It’s unclear whether the pot use in adolescence may have led to more severe substance abuse or was an early sign of psychiatric or social factors that contributed to later disability, the researchers caution.